Understanding diabetes in patients with HIV/AIDS
Open Access
- 14 January 2011
- journal article
- Published by Springer Science and Business Media LLC in Diabetology & Metabolic Syndrome
- Vol. 3 (1), 2-7
- https://doi.org/10.1186/1758-5996-3-2
Abstract
This paper reviews the incidence, pathogenetic mechanisms and management strategies of diabetes mellitus in patients with human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). It classifies patients based on the aetiopathogenetic mechanisms, and proposes rational methods of management of the condition, based on aetiopathogenesis and concomitant pharmacotherapy.Keywords
This publication has 41 references indexed in Scilit:
- A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalizationGlobalization and Health, 2009
- Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected PatientsDiabetes Care, 2008
- HIV Therapy and Diabetes RiskDiabetes Care, 2008
- Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adultsAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- Metabolic Syndrome in HIV-Infected Patients from an Urban, Midwestern US Outpatient PopulationClinical Infectious Diseases, 2007
- CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trialThe Lancet, 2006
- Hyperglycemia in HIV/AIDSDiabetes Spectrum, 2006
- Disorders of glucose metabolism in the context of human immunodeficiency virus infectionJournal of the American Academy of Nurse Practitioners, 2006
- New Drugs and Diabetes Risk: Antipsychotic and Antiretroviral AgentsPublished by Elsevier BV ,2006
- Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapyAIDS, 2003